AIM2 and melanoma: We also assessed the expression of other inflammasome-forming PRRs, there was no significant differences of the mRNA expression of NLRP1, NLRC4 (NLR family CARD-containing 4), and AIM2 (absent in melanoma 2) between vehicle- and MGO-treated groups (Supplementary Fig. S1).